The induction of bone formation by the recombinant human transforming growth factor-β3

Biomaterials

Volumn 35, Issue 9, 2014, Pages 2773-2788

  Klar, Roland M ^a   Duarte, Raquel ^b   Dix Peek, Therese ^b   Ripamonti, Ugo ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Bone morphogenetic proteins; Noggin; Primates; QRT PCR; Tissue induction; Transforming growth factor 3

Indexed keywords

BONE MORPHOGENETIC PROTEINS; NOGGIN; PRIMATES; QRT-PCR; TISSUE INDUCTION; TRANSFORMING GROWTH FACTOR-Β(3);

ANIMALS; BIOREACTORS; CALCIUM CARBONATE; CARRIER PROTEINS; DURAPATITE; GENE EXPRESSION REGULATION; HUMANS; MORPHOGENESIS; OSTEOGENESIS; PAPIO URSINUS; POROSITY; PROSTHESIS IMPLANTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA3;

EID: 84894997668     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.12.062     Document Type: Article

References (66)

1. Reddi A.H. Bone morphogenesis and modelling: soluble signals sculpt osteosomes in the solid state. Cell 1997, 89:159-161.
2. Reddi A.H. Morphogenesis and tissue engineering of bone and cartilage: inductive signals, stem cells, and biomimetic biomaterials. Tissue Eng 2000, 6:351-359.
3. Ripamonti U. Biomimetism, biomimetic matrices and the induction of bone formation. JCell Mol Med 2009, 13:2953-2972.
4. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., et al. Novel regulators of bone formation: molecular clones and activities. Science 1988, 242:1528-1534.
5. ten Dijke P., Iwata K.K., Goddard C., Pieter C., Canalis E., McCarthy T.L., et al. Recombinant transforming growth factor type beta 3: biological activities and receptor-binding properties in isolated bone cells. Mol Cell Biol 1990, 10:4473-4479.
6. Massagué J. How cells read TGF-β signals. Nat Rev Mol Cell Biol 2000, 3:169-178.
7. Ripamonti U. Soluble osteogenic molecular signals and the induction of bone formation. Biomaterials 2006, 27:807-822.
8. Balooch G., Balooch M., Nalla R.K., Schilling S., Filvaroff E.H., Marshal G.W., et al. TGFβ regulates the mechanical properties and composition of bone matrix. Proc Natl Acad Sci U S A 2005, 102:18813-18818.
9. Spagnoli A., O'Rear L., Chandler R.L., Granero-Molto F., Mortlock D.P., Gorska A.E., et al. TGF-β signalling is essential for joint morphogenesis. JCell Biol 2007, 177:1105-1117.
10. Roberts A.B., Sporn M.B., Assoian R.K., Smith J.M., Roche N.S., Wakefield L.M., et al. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis invivo and stimulation of collagen formation invitro. Proc Natl Acad Sci U S A 1986, 83:4167-4171.
11. 1 modulates the expression of vascular endothelial growth factor by osteoblasts. Am J Phys 1999, 277:C628-C637.
12. Sampath T.K., Muthukumaran N., Reddi A.H. Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. Proc Natl Acad Sci U S A 1987, 84:7109-7113.
13. Hammonds R.G., Schwall R., Dudley A., Berkemeier L., Lai C., Lee J., et al. Bone inducing activity of mature BMP-2b produced from a hybrid BMP-2a/2b precursor. Mol Endocrinol 1991, 5:149-155.
14. Shinozaki M., Kawara S., Hayashi N., Kakinuma T., Igarashi A., Takehara K. Induction of subcutaneous tissue fibrosis in newborn mice by transforming growth factor β-simultaneous application with basic fibroblast growth factor causes persistent fibrosis. Biochem Biophys Res Commun 1997, 240:292-297.
15. Shah M., Foreman D.M., Ferguson M.W. Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. JCell Sci 1995, 108:985-1002.
16. Ripamonti U., Ramoshebi L.N., Patton J., Matsaba T., Teare J., Renton L. Soluble signals and insoluble substrata: novel molecular cues instructing the induction of bone. The skeleton 2004, 217-227. Humana Press, New York. E.J. Massaro, J.M. Rogers (Eds.).
17. 1 induces endochondral bone in the baboon and synergizes with recombinant osteogenic protein-1 (bone morphogenetic protein-7) to initiate rapid bone formation. JBone Miner Res 1997, 2:1584-1595.
18. 2 in the baboon (Papio ursinus). Growth Factors 2000, 17:269-285.
19. 3: experimental studies in the non-human primate Papio ursinus. JCell Mol Med 2008, 12:1029-1048.
20. 2 in the non-human primate Papio ursinus and its modulation by skeletal muscle responding stem cells. Cell Prolif 2010, 43:207-218.
21. Ripamonti U., Ferretti C., Teare J., Blann L. Transforming growth factor-β isoforms and the induction of bone formation: Implications for reconstructive craniofacial surgery. JCraniofac Surg 2009, 20:1544-1555.
22. Ripamonti U., Van Den Heever B., Crooks J., Tucker M.M., Sampath T.K., Rueger D.C., et al. Long-term evaluation of bone formation by osteogenic protein 1 in the baboon and relative efficacy of bone-derived bone morphogenetic proteins delivered by irradiated xenogeneic collagenous matrices. JBone Miner Res 2000, 9:1798-1809.
23. Ripamonti U. Osteogenic proteins of the transforming growth factor-β superfamily. Encyclopaedia of hormones 2003, 80-86. Austin Academic Press, Texas. H.L. Henry, A.W. Norman (Eds.).
24. Ripamonti U. Bone induction by recombinant human osteogenic protein-1 (hOP-1, BMP-7) in the primate Papio ursinus with expression of mRNA of gene products of the TGF-β superfamily. JCell Mol Med 2005, 9:911-928.
25. Ripamonti U. Inductive bone matrix and porous hydroxyapatite composites in rodents and non-human primates. Handbook of bioactive ceramics, calcium phosphate and hydroxylapatite ceramics 1990, vol. II:245-253. CRC Press, Florida.
26. Ripamonti U. The morphogenesis of bone in replicas of porous hydroxyapatite obtained from conversion of calcium carbonate exoskeletons of coral. JBone Joint Surg Am 1991, 73:692-703.
27. Shors E.C. Coralline bone graft substitutes. Orthop Clin North Am 1999, 30:599-613.
28. Ripamonti U., Crooks J., Khoali L., Roden L. The induction of bone formation by coral-derived calcium carbonate/hydroxyapatite constructs. Biomaterials 2009, 30:1428-1439.
29. Ripamonti U., Klar R.M., Renton L.F., Ferretti C. Synergistic induction of bone formation by hOP-1, hTGF-β3 and inhibition by zoledronate in macroporous coral-derived hydroxyapatites. Biomaterials 2010, 31:6400-6410.
30. Schnitzler C.M., Ripamonti U., Mesquita J.M. Histomorphometry of iliac crest trabecular bone in adult male baboons in captivity. Calcif Tissue Int 1993, 52:447-454.
31. Public Service Department National code for animal use in research education, diagnosis and testing of drugs and related substances in South Africa 1990, Public Service Department, Pretoria, South Africa.
32. Klar R.M., Duarte R., Dix-Peek T., Dickens C., Ferretti C., Ripamonti U. Calcium ions and osteoclastogenesis initiate the induction of bone formation by coral-derived macroporous constructs. JCell Mol Med 2013, 10.1111/jcmm.12125.
33. Ripamonti U., van Den Heever B., van Wyk J. Expression of the osteogenic phenotype in porous hydroxyapatite implanted extraskeletally in baboons. Matrix 1993, 13:491-502.
34. 1: induction of bone morphogenetic protein genes expression during endochondral bone formation in the baboon, and synergistic interaction with osteogenic protein-1 (BMP-7). Growth Factors 1998, 15:259-277.
35. Shi Y., Massagué J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
36. Matsunobu T., Torigoe K., Ishikawa M., de Vega S., Kulkarni A.B., Iwamoto Y., et al. Critical roles of the TGF-β type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development. Dev Biol 2009, 2:325-338.
37. Bandyopadhyay A., Tsuji K., Cox K., Harfe B.D., Rosen V., Tabin C.J. Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet 2006, 12:e216.
38. Huang Z., Ren P.G., Ma T., Smith R.L., Goodman S.B. Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine 2010, 51:305-310.
39. Noel D., Gazit D., Bouquet C., Apparailly F., Bony C., Plence P., et al. Short-term BMP-2 expression is sufficient for invivo osteochondral differentiation of mesenchymal stem cells. Stem Cells 2004, 22:74-85.
40. Zimmerman L.B., De Jesus-Escobar J.M., Harland R.M. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 1996, 96:599-606.
41. Zhou Z., Xie J., Lee D., Liu Y., Jung J., Zhou L., et al. Neogenin regulation of BMP-induced canonical Smad signaling and endochondral bone formation. Dev Cell 2010, 19:90-102.
42. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.
43. Pretheeban T., Lemos D.R., Paylor B., Zhang R.H., Rossi F.M. Role of stem/progenitor cells in reparative disorders. Fibrogenesis Tissue Repair 2012, 5:1-20.
44. De Robertis E.M. Evo-Devo: the merging of evolutionary and developmental biology. Pontif Acad Sci Acta 2011, vol. 21:221-235.
45. Chen G., Deng C., Li Y.P. TGF-β and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 2012, 8:272-288.
46. Miyazono K., Kusanagi K., Inoue H. Divergence and convergence of TGF-β/BMP signaling. JCell Physiol 2001, 187:265-276.
47. Heldin C.H., Miyazono K., ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 1997, 390:465-471.
48. Miyazono K., ten Dijke P., Heldin C.H. TGF-β signaling by Smad proteins. Adv Immunol 2000, 75:115-157.
49. Miyazono K. Positive and negative regulation of TGF-β signaling. JCell Sci 2000, 113:1101-1109.
50. Cooper G.M., Usas A., Olshanski A., Mooney M.P., Losee J.E., Huard J. Exvivo Noggin gene therapy inhibits bone formation in a mouse model of postoperative resynostosis. Plast Reconstr Surg 2009, 123:94S-103S.
51. Onichtchouk D., Chen Y.G., Dosch R., Gawantka V., Delius H., Massagué J., et al. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 1999, 401:480-485.
52. Gazzerro E., Smerdel-Ramoya A., Zanotti S., Stadmeyer L., Durant D., Economides A.N., et al. Conditional deletion of gremlin causes a transient increase in bone formation and bone mass. JBiol Chem 2007, 282:31549-31557.
53. 1 as possible link between loss of bone mineral density and chronic inflammation. PLoS One 2010, 5:e14073.
54. 1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy?. BMC Med 2012, 10:101.
55. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
56. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
57. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:1-12.
58. Harada S., Rodan G.A. Control of osteoblast function and regulation of bone mass. Nature 2003, 423:349-355.
59. Takeda S., Bonnamy J.P., Owen M.J., Ducy P., Karsenty G. Continuous expression of Cbfa1 in non-hypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev 2001, 15:467-481.
60. Ripamonti U., van den Heever B., Sampath T.K., Tucker M.M., Rueger D.C., Reddi A.H. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7). Growth Factors 1996, 13:273-289.
61. Slack J.M.W. Morphogenetic gradients - past and present. Trends Biochem 1987, 12:200-204.
62. Lander A.D. Morpheus unbound: reimagining the morphogen gradient. Cell 2007, 128:245-256.
63. 3. Keystone symposia on regenerative tissue engineering. Breckenridge CO 2012, http://www.keystonesymposia.org, R.S. Tuan, F. Guilak, A. Atala (Eds.).
64. Ripamonti U., Teare J., Ferretti C. Amacroporous bioreactor super activated by the recombinant human transforming growth factor-β3. Front Physiol 2012, 3:1-18.
65. Webster A.J., Payne R.J.H., Pagel M. Molecular phylogenies link rates of evolution and speciation. Science 2003, 301:478.
66. Ezard T.H.G., Thomas G.H., Purvis A. Inclusion of a near-complete fossil record reveals speciation-related molecular evolution. Methods Ecol Evol 2013, 4:745-753.